Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Trends and Prospects in Metacognition Research by

bigCover of the book Public Program Analysis by

bigCover of the book Color Atlas of Xenopus laevis Histology by

bigCover of the book Gene Transfer in the Cardiovascular System by

bigCover of the book Oesophageal Atresia by

bigCover of the book The Relation of Theoretical and Applied Linguistics by

bigCover of the book Alterations in the Neuronal Cytoskeleton in Alzheimer Disease by

bigCover of the book Like Son, Like Father by

bigCover of the book New Directions in Lemur Studies by

bigCover of the book Child Sexual Abuse by

bigCover of the book The Kidney in Pregnancy by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy